Vitamin D Treatment Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an Animal Model of Parkinson’s Disease, Shifting M1 to M2 Microglia Responses

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Neuroimmune Pharmacology

• Publication date

  2017-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11481-016-9720-7PMID 27987058
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Parkinson's disease].

  2022cited by this paper
• Vitamin D3 alters microglia immune activation by an IL-10 dependent SOCS3 mechanism.

  2016cited by this paper
• Transcranial Direct Current Stimulation Modulates Neurogenesis and Microglia Activation in the Mouse Brain

  2016cited by this paper
• 1,25-Dihydroxyvitamin D3 Facilitates M2 Polarization and Upregulates TLR10 Expression on Human Microglial Cells

  2016influential reference
• Vitamin D Protects Against Atherosclerosis via Regulation of Cholesterol Efflux and Macrophage Polarization in Hypercholesterolemic Swine

  2015cited by this paper
• M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide

  2015influential reference
• The effects of either resveratrol or exercise on macrophage infiltration and switching from M1 to M2 in high fat diet mice

  2015cited by this paper
• Emerging therapies for Parkinson's disease: from bench to bedside.

  2014cited by this paper
• Inflammatory response in Parkinson's disease (Review).

  2014cited by this paper
• Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases.

  2014cited by this paper
• Introduction to neuropathic pain syndromes.

  2014cited by this paper
• Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: Possible role of SOCS-1 in reducing pro-inflammatory responses

  2014cited by this paper
• Neural and Immune Mechanisms in the Pathogenesis of Parkinson’s Disease

  2013cited by this paper
• Regulation of TREM-1 expression by 1,25-dihydroxyvitamin D3 in human monocytes/macrophages.

  2013cited by this paper
• Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson’s Disease?

  2013cited by this paper
• Therapeutic prospects for Parkinson disease

  2013cited by this paper
• In Vivo Molecular Markers for Pro-inflammatory Cytokine M1 Stage and Resident Microglia in Trimethyltin-Induced Hippocampal Injury

  2013influential reference
• In Vivo Molecular Markers for Pro-inflammatory Cytokine M1 Stage and Resident Microglia in Trimethyltin-Induced Hippocampal Injury

  2013cited by this paper
• The History of the Discovery of Vitamin D and Its Daughter Steroid Hormone

  2012cited by this paper
• IL-10 Triggers Changes in Macrophage Phenotype That Promote Muscle Growth and Regeneration

  2012cited by this paper
• The Classification of Microglial Activation Phenotypes on Neurodegeneration and Regeneration in Alzheimer’s Disease Brain

  2012cited by this paper
• IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease

  2011cited by this paper
• Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat.

  2011cited by this paper
• Vitamin D3-Enriched Diet Correlates with a Decrease of Amyloid Plaques in the Brain of AβPP Transgenic Mice

  2011cited by this paper
• Macrophages in Injured Skeletal Muscle: A Perpetuum Mobile Causing and Limiting Fibrosis, Prompting or Restricting Resolution and Regeneration

  2011influential reference
• MPTP Mouse Models of Parkinson's Disease: An Update

  2011cited by this paper
• Macrophage and dendritic cell phenotypic diversity in the context of biomaterials.

  2011influential reference
• MPTP-Induced Neuroinflammation Increases the Expression of Pro-Inflammatory Cytokines and Their Receptors in Mouse Brain

  2010influential reference
• The regulation of IL-10 production by immune cells

  2010cited by this paper
• Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation.

  2010cited by this paper
• Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention.

  2010cited by this paper
• Biology of interleukin-10.

  2010cited by this paper
• Parkinson's disease (vol 373, pg 2055, 2009)

  2009cited by this paper
• 1,25‐Dihydroxyvitamin D3 administration to 6‐hydroxydopamine‐lesioned rats increases glial cell line‐derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum

  2009cited by this paper
• Neuroinflammation in Parkinson's disease: a target for neuroprotection?

  2009cited by this paper
• TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease

  2008cited by this paper
• Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease

  2008cited by this paper
• Macrophage Polarization in Bacterial Infections

  2008influential reference
• Vitamin effects on the immune system: vitamins A and D take centre stage

  2008cited by this paper
• Expression of TLR4 and CD14 in the Central Nervous System (CNS) in a MPTP Mouse Model of Parkinson's-Like Disease

  2008cited by this paper
• Inflammation as a causative factor in the aetiology of Parkinson's disease

  2007cited by this paper
• Protocol for the MPTP mouse model of Parkinson's disease

  2007cited by this paper
• Innate immune receptor expression in normal brain aging.

  2007cited by this paper
• Peripheral inflammatory biomarkers and risk of Parkinson's disease.

  2007cited by this paper
• Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

  2006influential reference
• Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.

  2006cited by this paper
• Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease

  2006influential reference
• 1α,25-Dihydroxyvitamin D3 Protects Dopaminergic Neurons in Rodent Models of Parkinson's Disease through Inhibition of Microglial Activation

  2006cited by this paper
• Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism.

  2005cited by this paper
• Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains

  2003cited by this paper
• Pathogenic role of glial cells in Parkinson's disease

  2003cited by this paper
• Neuro–glia interaction effects on GFAP gene: a novel role for transforming growth factor‐β1

  2002cited by this paper
• Enhanced Expression of Iba1, Ionized Calcium-Binding Adapter Molecule 1, After Transient Focal Cerebral Ischemia In Rat Brain

  2001cited by this paper
• Interleukin-10 and the interleukin-10 receptor.

  2001cited by this paper
• Vitamin D(3) attenuates cortical infarction induced by middle cerebral arterial ligation in rats.

  2000cited by this paper
• Growth factor function in the development and maintenance of midbrain dopaminergic neurons: concepts, facts and prospects for TGF-beta.

  1996cited by this paper
• TGF‐beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity.

  1995cited by this paper
• TGF-superfamily memberspromote survival of midbrain dopaminergic neuronsandprotect them against MPP+toxicity

  1995cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Cytokine associated neuroinflammation in Parkinson's disease: Molecular pathways, therapeutic targets, and translational insights.

  2026cites this paper
• Vitamin D and Brain Health.

  2026cites this paper
• Vitamin D and Sleep Disorders.

  2026cites this paper
• Disrupted Vitamin D Signaling and Metabolism in Neurodevelopmental and Neurodegenerative Disorders

  2026cites this paper
• Micronutrients and bioactive compounds in neuroprotection: Potential, mechanisms, and dietary sources

  2026cites this paper
• Reprogramming brain-resident macrophages: from disease drivers to therapeutic allies in neurological disorders.

  2026cites this paper
• Vitamin D-Mediated Immunoregulation in Degenerative Diseases: Insights into Cardiovascular, Neurodegenerative and Musculoskeletal Disorders.

  2026cites this paper
• Specific Peripheral Markers of Chronic Stress Load in the Pathogenesis of Depression: a Clinical Study

  2026cites this paper
• Association of vitamin D with depression prevalence in U.S. adults: a cross-sectional analysis from NHANES 2021 to 2023

  2025cites this paper
• The APOE isoforms differentially shape the transcriptomic and epigenomic landscapes of human microglia xenografted into a mouse model of Alzheimer’s disease

  2025cites this paper
• Rebamipide (Mucosta®), a clinically approved drug, alleviates neuroinflammation and dopaminergic neurodegeneration in a Parkinson’s disease model

  2025cites this paper
• Role and mechanism of molecular hydrogen in the treatment of Parkinson’s diseases

  2025cites this paper
• Menopause triggers microglia-associated neuroinflammation in Parkinson's disease.

  2025cites this paper
• Troxerutin attenuates LPS-induced inflammation in BV2 microglial cells involving Nrf2 activation and NF-κB pathway inhibition

  2025cites this paper
• Vitamin D3 and Vitamin A Synergistically Prevent Visuospatial Memory Impairment in Mice Model of the Dopaminergic System Disorder.

  2025cites this paper
• The Neuroprotective Potential of Vitamin D3

  2025influential citation
• Vitamin D Associated with Exercise Can Be Used as a Promising Tool in Neurodegenerative Disease Protection

  2025cites this paper
• Exercise Ameliorates Dopaminergic Neurodegeneration in Parkinson’s Disease Mice by Suppressing Microglia-Regulated Neuroinflammation Through Irisin/AMPK/Sirt1 Pathway

  2025cites this paper
• Targeting Neuronal Alpha7 Nicotinic Acetylcholine Receptor Upregulation in Age-Related Neurological Disorders

  2025cites this paper
• Impact of vitamin D3 supplementation on motor functionality and the immune response in Parkinson’s disease patients with vitamin D deficiency

  2025cites this paper
• Vitamin D and Neurodegenerative Diseases Such as Multiple Sclerosis (MS), Parkinson’s Disease (PD), Alzheimer’s Disease (AD), and Amyotrophic Lateral Sclerosis (ALS): A Review of Current Literature

  2025cites this paper
• Fucoxanthin alleviates secondary brain injury in mice following intracerebral hemorrhage via PI3K-mediated inhibition of NF-κB signaling pathway.

  2025cites this paper
• Vitamin D, B9, and B12 Deficiencies as Key Drivers of Clinical Severity and Metabolic Comorbidities in Major Psychiatric Disorders

  2025influential citation
• Unlocking the Potential of Vitamin D: A Comprehensive Exploration of Its Role in Neurological Health and Diseases

  2025cites this paper
• Moderate UVB exposure ameliorate chronic stress-induced anxiety and social impairment by activating mPFC to basal lateral amygdala pathway.

  2025cites this paper
• The Role of Vitamin D in Parkinson’s Disease: Evidence from Serum Concentrations, Supplementation, and VDR Gene Polymorphisms

  2025cites this paper
• Vitamin D-linked vulnerability and functional connectivity alterations in the superior frontal gyrus contributing to cognitive impairment in Parkinson’s disease

  2025cites this paper
• Microbiota-gut-brain axis in perioperative neurocognitive and depressive disorders: Pathogenesis to treatment.

  2024cites this paper
• Nutritional and Microbiota-Based Approaches in Amyotrophic Lateral Sclerosis: From Prevention to Treatment

  2024cites this paper
• Glial polarization in neurological diseases: molecular mechanisms and therapeutic opportunities.

  2024cites this paper
• The Role of Hypothalamic Microglia in the Onset of Insulin Resistance and Type 2 Diabetes: A Neuro-Immune Perspective

  2024cites this paper
• Brain inflammaging in the pathogenesis of late-life depression

  2024cites this paper
• Neuroplasticity-related effects of vitamin D relevant to its neuroprotective effects: A narrative review.

  2024cites this paper
• Vitamin D: The crucial neuroprotective factor for nerve cells.

  2024cites this paper
• Vitamin D Deficiency Does Not Affect Cognition and Neurogenesis in Adult C57Bl/6 Mice

  2024influential citation
• The Role of 25-OH Vitamin D in Alzheimer's Disease through Mendelian Randomization and MRI.

  2024cites this paper
• Differentiation and regulation of CD4+ T cell subsets in Parkinson’s disease

  2024cites this paper
• Cholecalciferol Supplementation Impacts Behavior and Hippocampal Neuroglial Reorganization in Vitamin D-Deficient Rats

  2024cites this paper
• Putative Pharmacological Depression and Anxiety-Related Targets of Calcitriol Explored by Network Pharmacology and Molecular Docking

  2024influential citation
• The APOE isoforms differentially shape the transcriptomic and epigenomic landscapes of human microglia in a xenotransplantation model of Alzheimer’s disease

  2024cites this paper
• Role of Calcitriol and Vitamin D Receptor (VDR) Gene Polymorphisms in Alzheimer’s Disease

  2024cites this paper
• Docosahexaenoic Acid (DHA), Vitamin D3, and Probiotics Supplementation Improve Memory, Glial Reactivity, and Oxidative Stress Biomarkers in an Aluminum-Induced Cognitive Impairment Rat Model

  2024cites this paper
• Ser9p-GSK3β Modulation Contributes to the Protective Effects of Vitamin C in Neuroinflammation

  2024cites this paper
• Neuroinflammation-induced neurodegeneration and associated microglia activation in Parkinson’s disease: a novel neurotherapeutic avenue

  2024cites this paper
• Calcitriol attenuates lipopolysaccharide-induced neuroinflammation and depressive-like behaviors by suppressing the P2X7R/NLRP3/caspase-1 pathway

  2024cites this paper
• Tremendous Fidelity of Vitamin D3 in Age-related Neurological Disorders

  2024influential citation
• Vitamin D Reduces GABA-Positive Astrocytes in the 5xFAD Mouse Model of Alzheimer’s Disease

  2024cites this paper
• ‘Unpredictable chronic mild stress does not exacerbate memory impairment or altered neuronal and glial plasticity in the hippocampus of middle‐aged vitamin D deficient mice’

  2024cites this paper
• Unravelling the role of nutraceutical supplements in treatment of Parkinson’s Disease

  2024cites this paper
• Profiling inflammatory mechanisms, hyperphosphorylated tau of hippocampal tissue and spatial memory following vitamin D3 treatment in the mice model of vascular dementia.

  2023cites this paper
• New insight on microglia activation in neurodegenerative diseases and therapeutics

  2023cites this paper
• Levodopa-induced dyskinesia: interplay between the N-methyl-D-aspartic acid receptor and neuroinflammation

  2023cites this paper
• Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

  2023cites this paper
• The neuroprotective effect of vitamin D in Parkinson's disease: association or causation

  2023cites this paper
• Does vitamin D protect or treat Parkinson’s disease? A narrative review

  2023cites this paper
• Microglia and Brain Disorders: The Role of Vitamin D and Its Receptor

  2023cites this paper
• Vitamin D deficiency and genetic polymorphisms of vitamin D‐associated genes in Parkinson's disease

  2023cites this paper
• Unprecedented effect of vitamin D3 on T-cell receptor beta subunit and alpha7 nicotinic acetylcholine receptor expression in a 3-nitropropionic acid induced mouse model of Huntington’s disease

  2023cites this paper
• The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update

  2023cites this paper
• Vitamin D and neurodegenerative diseases

  2023cites this paper
• Implications of vitamin D deficiency in systemic inflammation and cardiovascular health

  2023cites this paper
• Understanding the Molecular Aspects of Vitamins in Parkinson's Disease: Present-day Concepts and Perspectives.

  2023cites this paper
• Nitric Oxide/Nitric Oxide Synthase System in the Pathogenesis of Neurodegenerative Disorders—An Overview

  2023cites this paper
• Neuroinflammation in Alzheimer’s disease: potential beneficial effects of vitamin D

  2023cites this paper
• Impact of vitamin D on the prognosis after spinal cord injury: A systematic review

  2023cites this paper
• Could Vitamins Have a Positive Impact on the Treatment of Parkinson’s Disease?

  2023cites this paper
• Potential of Neuroinflammation-Modulating Strategies in Tuberculous Meningitis: Targeting Microglia

  2023cites this paper
• The Potential Role of Vitamin D Supplementation In Cognitive Impairment Prevention.

  2023cites this paper
• Bioactive Compounds of the Mediterranean Diet as Nutritional Support to Fight Neurodegenerative Disease

  2023cites this paper
• Therapeutic effect of combination vitamin D3 and siponimod on remyelination and modulate microglia activation in cuprizone mouse model of multiple sclerosis

  2023cites this paper
• Vitamin D metabolites and analytical challenges.

  2023cites this paper
• [Vitamin D and other indicators of calcium-phosphorus metabolism as possible predictors of Parkinson's disease].

  2022cites this paper
• Inflammaging and Brain: Curcumin and Its Beneficial Potential as Regulator of Microglia Activation

  2022cites this paper
• Changes in the macular choroidal thickness of children who have type-1 diabetes mellitus, with and without vitamin D deficiency

  2022cites this paper
• Astrocytes expressing Vitamin D‐activating enzyme identify Parkinson’s disease

  2022cites this paper
• Association of preoperative vitamin D deficiency with the risk of postoperative delirium and cognitive dysfunction: A meta-analysis.

  2022cites this paper
• Vitamin D and Parkinson’s Disease

  2022cites this paper
• Restorative action of vitamin D3 on motor dysfunction through enhancement of neurotrophins and antioxidant expression in the striatum.

  2022cites this paper
• The neuroprotective roles of Dietary Micronutrients on Parkinson’s disease: a review

  2022cites this paper
• Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective?

  2022cites this paper
• Bioactive Natural Compounds for Therapeutic and Nutraceutical Applications in Neurodegeneration

  2022cites this paper
• Exosomes and their Cargo as a New Avenue for Brain and Treatment of CNS- Related Diseases

  2022cites this paper
• Molecular Basis Underlying the Therapeutic Potential of Vitamin D for the Treatment of Depression and Anxiety

  2022cites this paper
• Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications

  2022influential citation
• A Dietary Supplement Containing Micronutrients, Phosphatidylserine, and Docosahexaenoic Acid Counteracts Cognitive Impairment in D-Galactose-Induced Aged Rats

  2022cites this paper
• The Role of Vitamin D in Alzheimer’s Disease: A Transcriptional Regulator of Amyloidopathy and Gliopathy

  2022cites this paper
• Therapeutic and mechanistic intervention of vitamin D in neuropsychiatric disorders.

  2022cites this paper
• Physiological and Pathological Functions of Neuronal Hemoglobin: A Key Underappreciated Protein in Parkinson’s Disease

  2022cites this paper
• KL-FGF23-VD Axis in Improving Late-Onset Alzheimer's Disease by Modulating IKK/NF-κB Signal Pathway

  2022cites this paper
• Dexmedetomidine post-conditioning protects blood-brain barrier integrity by modulating microglia/macrophage polarization via inhibiting NF-κB signaling pathway in intracerebral hemorrhage

  2022cites this paper
• Increased PRR14 and VCAM-1 level in serum of patients with Parkinson's disease

  2022cites this paper
• Vitamin D3 exerts immunomodulatory and memory improving properties in rats with lipopolysaccharide-induced inflammation.

  2022cites this paper
• Vitamin D3 Supplementation Attenuates Surgery-Induced Neuroinflammation and Cognitive Impairment by Regulating NLRP3 Inflammasome in Mice

  2022cites this paper
• Mechanisms of Autoimmune Cell in DA Neuron Apoptosis of Parkinson's Disease: Recent Advancement

  2022cites this paper
• Understanding the role of "sunshine vitamin D" in Parkinson’s disease: A review

  2022cites this paper
• Vitamin D and schizophrenia: 20 years on

  2021cites this paper
• Fibroblast Growth Factor 21 Modulates Microglial Polarization That Attenuates Neurodegeneration in Mice and Cellular Models of Parkinson's Disease

  2021cites this paper
• Assessing the Effects of Vitamin D on Neural Network Function in Patients With Parkinson’s Disease by Measuring the Fraction Amplitude of Low-Frequency Fluctuation

  2021cites this paper
• Screening of Parkinson's Differential MicroRNA Based on GEO Database and Its Clinical Verification

  2021cites this paper
• Mechanisms Involved in Microglial-Interceded Alzheimer’s Disease and Nanocarrier-Based Treatment Approaches

  2021cites this paper